How to Help Your Patients Save Money on Myobloc: A Provider's Guide to Savings Programs

Myobloc (rimabotulinumtoxinB) is an expensive brand-only specialty injectable. Without appropriate financial support, the cost burden can be significant — and can cause patients to delay or forgo treatment. As a prescriber, you play a key role in connecting patients with cost-reduction resources. This guide reviews every available savings mechanism.

Understanding the Cost Landscape

The average retail price of Myobloc is approximately $1,777 per 10,000-unit/2 mL vial. For cervical dystonia treatment — which may require doses up to 12,500 units, 3–4 times per year — annual medication costs can range from $5,000 to over $20,000 depending on dose and frequency. This is before factoring in the clinical administration fees charged by the practice.

Key coverage facts:

Medicare: Myobloc is NOT covered by any Medicare plan (neither Part B nor Part D). This is a major hardship for your older patients.

Commercial insurance: Requires prior authorization and typically step therapy through type A toxins. When approved, patient cost-sharing varies widely by plan.

Medicaid: Coverage varies significantly by state. Manufacturer copay programs are NOT available for Medicaid patients.

Program 1: Myobloc Manufacturer Copay Program

This is the most powerful tool for commercially insured patients. Key details:

Benefit: Eligible commercially insured patients may pay $0 for Myobloc medication AND administrative services up to $4,000/year

Eligibility: Commercially insured patients only — excludes Medicare, Medicaid, TRICARE, and other federal/state program beneficiaries

Duration: Valid for 1 year per enrollment; renew annually

How to enroll: Contact Myobloc patient support at 1-888-461-2255 or visit myobloc.com. Your office staff can enroll patients or provide them with enrollment information.

Recommendation: Make copay program enrollment part of your standard workflow for every new Myobloc patient. Don't wait for patients to ask — proactively check eligibility at the time of the first prescription.

Program 2: Patient Assistance Program (PAP)

For uninsured or underinsured patients who do not qualify for the copay program, a PAP may be available through Supernus Pharmaceuticals. PAPs typically provide medication at low or no cost to patients who meet income-based eligibility criteria.

Contact Solstice Neurosciences / Supernus Pharmaceuticals at 1-888-461-2255 to inquire about PAP availability and application process

Encourage patients to search NeedyMeds.org and RxAssist.org for the most current program details

Your practice's social worker or financial navigator can often assist with PAP applications

Strategy 3: Insurance Prior Authorization Optimization

For commercially insured patients, a successful prior authorization is the foundation of long-term affordability. Best practices:

Thoroughly document the diagnosis (ICD-10: G24.3 for spasmodic torticollis / cervical dystonia; K11.7 for drooling/sialorrhea) and functional impairment

Document complete type A botulinum toxin history: product names, doses, treatment dates, and specific clinical outcomes

Include any available neutralizing antibody testing results

For denials, pursue peer-to-peer review immediately — most clinical pharmacists and medical directors approve Myobloc for well-documented type A resistance

Track PA expiration dates — most are 6 months (initial) and 12 months (renewal); set calendar reminders

Strategy 4: Billing Optimization for In-Office Administration

When Myobloc is purchased and administered in your office, correct billing is essential to maximize reimbursement and reduce practice cost:

Bill using the correct HCPCS code for rimabotulinumtoxinB (check current CMS code annually, as codes may change)

Document the number of units administered accurately — billing for the actual units used, not vial size

Review payer-specific coverage policies, particularly EOCCO/Prime Therapeutics, Cigna, Aetna, and BCBS networks which have detailed dosing limits for Myobloc

Note: Most payers have dosing limits — for example, 100 billable units per 84 days for cervical dystonia under EOCCO/Cigna policies. These limits are in HCPCS billing units, not Myobloc units — clarify with your billing team

Strategy 5: Prescription Discount Cards for Uninsured Patients

For patients who are uninsured, cash-paying, or not covered by the above programs, point them to discount card services. SingleCare reduces the retail price of Myobloc from approximately $1,777 to approximately $1,244 per vial at participating pharmacies. WellRx and GoodRx may offer similar pricing. These are useful bridges while other assistance is arranged.

Putting It Together: A Practice Workflow

At prescription: Verify insurance type (commercial vs. Medicare vs. Medicaid); initiate PA for commercial payers

For commercially insured: Enroll in manufacturer copay program at 1-888-461-2255

For uninsured/underinsured: Explore PAP eligibility; provide SingleCare/GoodRx card information

For Medicare patients: Discuss Botox (Part B-covered) as an alternative where clinically appropriate; explore state pharmaceutical assistance programs

If pharmacy access is a barrier: Direct patients to medfinder.com to locate which pharmacies have Myobloc in stock near them

For a broader clinical access overview, see: Myobloc: What Providers Need to Know in 2026. To refer patients to pharmacy search tools, visit medfinder for providers.